ACNP Task Force report on SSRIs and suicidal behavior in youth (Q36327813)

13 August 2017

1 reference

title

ACNP Task Force report on SSRIs and suicidal behavior in youth (English)

1 reference

13 August 2017

0 references

0 references

0 references

1 reference

4

William Beardslee

1 reference

13 August 2017

11

Karen D Wagner

1 reference

13 August 2017

2

Graham Emslie

1 reference

13 August 2017

J John Mann

1

1 reference

13 August 2017

Ross J Baldessarini

3

1 reference

13 August 2017

Jan A Fawcett

5

1 reference

13 August 2017

Frederick K Goodwin

6

1 reference

13 August 2017

Andrew C Leon

7

1 reference

13 August 2017

Herbert Y Meltzer

8

1 reference

13 August 2017

Neal D Ryan

9

1 reference

13 August 2017

David Shaffer

10

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

13 August 2017

Neuropsychopharmacology

1 reference

13 August 2017

31

1 reference

13 August 2017

3

1 reference

13 August 2017

473-492

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300958

13 August 2017

0 references

cites work

Risk of mania with antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Childhood chemotherapy and later drug abuse and growth curve: a follow-up study of 30 adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Antidepressant medication and suicide in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Trends in hanging and firearm suicide rates in Australia: substitution of method?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

The relationship between antidepressant medication use and rate of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Tricyclic drugs for depression in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Antidepressants and public health in Iceland. Time series analysis of national data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Suicide prevention – a medical breakthrough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

The utilization of antidepressants--a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Antidepressant medications and the relative risk of suicide attempt and suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

A current perspective of suicide and attempted suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Secular trends in antidepressant prescribing in the UK, 1975-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

National trends in the outpatient treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Depressed Adolescents Grown Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

Psychotropic practice patterns for youth: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

The Maudsley long-term follow-up of child and adolescent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Clinical assessment versus research methods in the assessment of suicidal behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Suicidal behavior and psychotropic medication. Accepted as a consensus statement by the ACNP Council, March 2, 1992

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Antidepressants and suicide mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Childhood depression and risk of suicide: a preliminary report of a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Decreasing suicide in Hungary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Fluoxetine, Akathisia, and Suicidality: Is There a Causal Connection?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300958

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300958

1 reference

13 August 2017

1 reference